Exudative retinal astrocytic hamartoma diagnosed and treated with pars plana vitrectomy and intravitreal bevacizumab

Eye (Lond). 2012 Sep;26(9):1272-3. doi: 10.1038/eye.2012.124. Epub 2012 Jun 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Astrocytes / pathology
  • Bevacizumab
  • Biomarkers, Tumor / metabolism
  • Combined Modality Therapy
  • Exudates and Transudates
  • Fluorescein Angiography
  • Glial Fibrillary Acidic Protein / metabolism
  • Hamartoma / diagnosis*
  • Hamartoma / therapy*
  • Humans
  • Intravitreal Injections
  • Male
  • Neuroglia / pathology
  • Retinal Diseases / diagnosis*
  • Retinal Diseases / therapy*
  • Retinal Neovascularization / diagnosis
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity
  • Vitrectomy*
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Glial Fibrillary Acidic Protein
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab